Establishment Labs Hldgs saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 76 to 81.
This proprietary rating tracks technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks matches up against other publicly traded companies.
Decades of market research reveals that the top-performing stocks often have an RS Rating north of 80 as they launch their biggest climbs.
Risk Management In The Stock Market: How Much Money To Invest Now
While Establishment Labs Hldgs is not near a proper entry right now, see if it manages to form and break out of a proper base.
The company reported 0% earnings growth in its most recent report. Sales rose 4%.
The company earns the No. 59 rank among its peers in the Medical-Products industry group. Globus Medical, Penumbra and Boston Scientific are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
